Literature DB >> 17229020

Experimental models of Paget's disease.

Noriyoshi Kurihara1, Hua Zhou, Sakamuri V Reddy, Veronica Garcia Palacios, Mark A Subler, David W Dempster, Jolene J Windle, G David Roodman.   

Abstract

UNLABELLED: We targeted the MVNP gene to the OCL lineage in transgenic mice. These mice developed abnormal OCLs and bone lesions similar to those found in Paget's patients. These results show that persistent expression of MVNP in OCLs can induce pagetic-like bone lesions in vivo.
INTRODUCTION: Paget's disease (PD) is one of the most exaggerated examples of abnormal bone remodeling, with increased bone resorption and excessive new bone formation. However, its etiology is unclear. A viral etiology for PD has been suggested based on the presence of paramyxoviral-like nuclear inclusions, detection of measles virus nucleocapsid (MVNP) mRNA or protein in osteoclasts (OCLs) from PD lesions, and in vitro studies showing that transfection of normal OCL precursors with the MVNP gene results in formation of OCLs that express a pagetic phenotype (increased numbers of OCLs; increased responsivity to 1,25(OH)(2)D(3), RANKL, and TNF-alpha; increased expression of the TAF(II)-17 gene, and increased bone resorption capacity).
MATERIALS AND METHODS: We targeted MVNP to cells in the OCL lineage in transgenic mice using the TRACP promoter.
RESULTS: Histomorphometric analysis showed that there was a 64% increase in OCL perimeter (p = 6.0002) and 37% increase in osteoblast (OBL) perimeter in MVNP mice. In a mouse that was 14 months of age, there was a 225% increase in OBL perimeter and 149% in OBL perimeter. This was accompanied by increased cancellous bone volume (83%) and trabecular width (47%) and number (25%), with a marked increase in the amount of woven bone. In contrast, cancellous bone volume decreased between 3 and 12 months in wildtype (WT) mice, whereas cancellous bone volume in MVNP mice increased over the same time period. Ex vivo studies showed that the numbers of OCLs formed in marrow cultures from MVNP mice were increased, and the OCLs were hyper-responsive to 1,25(OH)(2)D(3) and had an increased bone resorbing capacity compared with WT cultures.
CONCLUSION: These results show that expression of MVNP in OCL in vivo results in a bone phenotype that is characteristic of PD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17229020     DOI: 10.1359/jbmr.06s210

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  7 in total

1.  Opposite spectrum of activity of canonical Wnt signaling in the osteogenic context of undifferentiated and differentiated mesenchymal cells: implications for tissue engineering.

Authors:  Natalina Quarto; Björn Behr; Michael T Longaker
Journal:  Tissue Eng Part A       Date:  2010-10       Impact factor: 3.845

Review 2.  Role of NF-κB in the skeleton.

Authors:  Deborah Veis Novack
Journal:  Cell Res       Date:  2010-11-16       Impact factor: 25.617

3.  Paget's disease: epidemiology and pathophysiology.

Authors:  Margaret Seton
Journal:  Curr Osteoporos Rep       Date:  2008-12       Impact factor: 5.096

4.  Coupling bone degradation to formation.

Authors:  Jameel Iqbal; Li Sun; Mone Zaidi
Journal:  Nat Med       Date:  2009-07       Impact factor: 53.440

5.  Paget's Disease of Bone: A Review of Epidemiology, Pathophysiology and Management.

Authors:  Joseph L Shaker
Journal:  Ther Adv Musculoskelet Dis       Date:  2009-04       Impact factor: 5.346

6.  Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62P394L mouse model of Paget's disease.

Authors:  Anna Daroszewska; Lorraine Rose; Nadine Sarsam; Gemma Charlesworth; Amanda Prior; Kenneth Rose; Stuart H Ralston; Robert J van 't Hof
Journal:  Dis Model Mech       Date:  2018-08-23       Impact factor: 5.758

7.  Increased S1P expression in osteoclasts enhances bone formation in an animal model of Paget's disease.

Authors:  Yuki Nagata; Kazuaki Miyagawa; Yasuhisa Ohata; Daniela N Petrusca; Gabriel M Pagnotti; Khalid S Mohammad; Theresa A Guise; Jolene J Windle; G David Roodman; Noriyoshi Kurihara
Journal:  J Cell Biochem       Date:  2020-10-27       Impact factor: 4.429

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.